NCT05208671

Brief Summary

The NOURISH-OK Study will identify how food insecurity contributes to insulin resistance, an important surrogate marker of many co-morbidities in HIV disease, using an integrated framework to identify key leverage points for insulin resistance. Drawing from these pathways, this study will adapt and evaluate a community-driven, science-informed "food as medicine" intervention designed to lower insulin resistance through healthy food access, food utilization skills, and other self-care behaviors. Knowledge gained from this study can benefit those living with HIV through the prevention and more effective management of pre-diabetes, diabetes, obesity, and non-alcoholic fatty liver disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
675

participants targeted

Target at P75+ for not_applicable hiv

Timeline
Completed

Started Oct 2020

Longer than P75 for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 9, 2020

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

January 11, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 26, 2022

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2025

Completed
18 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 17, 2025

Completed
Last Updated

June 2, 2026

Status Verified

May 1, 2026

Enrollment Period

5.1 years

First QC Date

January 11, 2022

Last Update Submit

May 28, 2026

Conditions

Keywords

food as medicinenutrition

Outcome Measures

Primary Outcomes (1)

  • Change from baseline insulin sensitivity at 12-weeks

    Quantitative Insulin-Sensitivity Check Index (QUICKI)

    Baseline; 12-weeks

Secondary Outcomes (4)

  • Change from baseline food security at 6-weeks, 12-weeks, and 16-weeks

    Baseline; 6-weeks; 12-weeks; 16-weeks

  • Change from baseline dietary intake at 6-weeks, 12-weeks, and 16-weeks

    Baseline; 6-weeks; 12-weeks; 16-weeks

  • Change from baseline skin carotenoid at 12-weeks

    Baseline; 12-weeks

  • Change from baseline chronic inflammation at 12-weeks

    Baseline; 12-weeks

Other Outcomes (1)

  • Change from baseline gut microbiome composition at 12-weeks

    Baseline; 12-weeks

Study Arms (2)

NOURISH Food Box

EXPERIMENTAL

12-week food assistance with low Dietary Inflammatory Index (DII) foods

Other: NOURISH Food Box

Wait-list Control

NO INTERVENTION

Wait-list control group eligible to receive NOURISH box after study period

Interventions

Selection of healthy groceries designed to reduce chronic inflammation and improve insulin resistance with healthy cooking/self-care curriculum

NOURISH Food Box

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HIV-positive with income \<400% federal poverty level
  • at least 1 risk factor for insulin resistance per the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (i.e., overweight/obesity, age 45 yrs or older, immediate family member with diabetes, non-white race, physical inactivity, history of gestational diabetes, history of heart disease or stroke, diagnosis of polycystic ovarian syndrome, high blood pressure, high cholesterol, or hepatitis C virus antibody positivity
  • using antiretroviral therapy for at least 6 months
  • English-speaking

You may not qualify if:

  • participating in another health-related research study
  • receiving treatment for a terminal or other serious illness, such as cancer or end-stage renal failure
  • plan to move outside of Oklahoma during the study period
  • does not have an address that can accept home-delivered groceries

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OU Integrative Immunology Center

Tulsa, Oklahoma, 74135, United States

Location

Related Publications (1)

  • Wetherill MS, Bakhsh C, Caywood L, Williams MB, Hartwell ML, Wheeler DL, Hubach RD, Teague TK, Kohler G, Hebert JR, Weiser SD. Unpacking determinants and consequences of food insecurity for insulin resistance among people living with HIV: Conceptual framework and protocol for the NOURISH-OK study. Front Clin Diabetes Healthc. 2022;3:947552. doi: 10.3389/fcdhc.2022.947552. Epub 2022 Aug 16.

Related Links

MeSH Terms

Conditions

Insulin Resistance

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Marianna S Wetherill, PhD, MPH, RD

    University of Oklahoma

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 11, 2022

First Posted

January 26, 2022

Study Start

October 9, 2020

Primary Completion

October 30, 2025

Study Completion

November 17, 2025

Last Updated

June 2, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Made available within 12 months of study end.
Access Criteria
Written request to PI.

Locations